Methylphenidate Hydrochloride Tablet, Extended Release
Product Images NDC 72162-2394

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Methylphenidate Hydrochloride (NDC 72162-2394). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl721622394)

Label for Methylphenidate Hydrochloride Extended-Release Tablets, USP, 36 mg strength. The label shows the product as 100 tablets, Rx only. It is relabeled by Bryant Ranch Prepack, Inc. and manufactured by Kremers Urban Pharmaceuticals Inc. The label includes storage instructions and QR codes for a medication guide and dosage information.*

FDA Label Image

Chemical Structure (Methylphenidate Hydrochloride Extended Release Tab 1)

Chemical structure of Methylphenidate Hydrochloride, showing its molecular arrangement including a phenyl ring, ester group, and piperidine ring with hydrochloride attachment.*

FDA Label Image

Figure 1 (Methylphenidate Hydrochloride Extended Release Tab 2)

A line graph depicting mean plasma methylphenidate concentration (ng/mL) over time (hours) comparing Methylphenidate HCl 18 mg once daily dosing with 5 mg three times daily dosing. The x-axis shows time from 0 to 32 hours, and the y-axis shows concentration from 0 to 5 ng/mL, illustrating plasma drug levels over the period following administration.*

FDA Label Image

Figure 2 (Methylphenidate Hydrochloride Extended Release Tab 3)

A bar chart comparing Methylphenidate Hydrochloride once daily and placebo on the Inattention/Overactivity Scale across three studies. The vertical axis shows symptom scores from 0 to 15, with black bars representing Methylphenidate HCl and white bars representing placebo. Each study presents different score values for both treatments.*

FDA Label Image

Figure 3 (Methylphenidate Hydrochloride Extended Release Tab 4)

Line graph showing the combined attention subscale over 12 hours post initial dose for Methylphenidate Hydrochloride 36 mg extended-release tablet compared to placebo. The x-axis represents hours post initial dose, and the y-axis represents attention levels from more attentive to less attentive. Methylphenidate group data is indicated with filled circles and a solid line, placebo with crosses and a dashed line, including mean and standard error values.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.